WAVE Life Sciences Ltd Stock
WAVE Life Sciences Ltd Stock
WAVE Life Sciences Ltd dominated the market today, gaining €0.25 (4.550%).
With 8 Buy predictions and not the single Sell prediction the community is currently very high on WAVE Life Sciences Ltd.
With a target price of 9 € there is a hugely positive potential of 56.52% for WAVE Life Sciences Ltd compared to the current price of 5.75 €.
So far the community has only identified positive things for WAVE Life Sciences Ltd stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of WAVE Life Sciences Ltd in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of WAVE Life Sciences Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| WAVE Life Sciences Ltd | 4.550% | 23.874% | -5.172% | 51.934% | 20.087% | 12.062% | - |
| Chromadex Corp | 1.810% | 10.759% | 4.790% | 180.000% | 161.194% | -51.389% | - |
| Organovo Holdings Inc. | 1.470% | -4.212% | -6.828% | -50.224% | -13.548% | -87.594% | -94.902% |
| Intellia Therapeutics Inc | 1.470% | 16.198% | -6.907% | -35.474% | -25.043% | -65.987% | 63.835% |
Comments
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $17.00 price target on the stock.
Show more
Ratings data for WVE provided by MarketBeat
Wave Life Sciences Ltd. (NASDAQ: WVE) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for WVE provided by MarketBeat
Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at Leerink Partnrs from a "market perform" rating to an "outperform" rating.
Show more
Ratings data for WVE provided by MarketBeat